Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caudal Ropivacaine with or without Dexmedetomidine for Pediatric Postoperative Analgesia
NCT05979558Completed
- Sponsor
- National Academy of Medical Sciences (India)
- Start
- Jun 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative pain comparing Ropivacaine + Dexmedetomidine with Ropivacaine + Placebo (2 arms). Primary endpoints: Duration of analgesia at 24 hours, revised Face, Legs, Activity, Cry, and Consolability score at 24 hours and 1 more. Started Jun 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05979558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05979558.